Introduction Peripheral neuropathy is a major risk factor for falls in adults with diabetes. Innovative footwear devices which artificially manipulate the sensory environment at the feet, such as ...

Journavx is the first truly new painkiller approved by the Food and Drug Administration in more than 20 years. But the drug is expensive, and many people can't get it yet.

Diabetic neuropathy, a common complication affecting up to 50% of individuals with diabetes, arises from nerve damage caused by prolonged high blood sugar. While conventional treatments focus on ...

Diabetic neuropathy pain can be effectively managed through a combination of medical treatment, lifestyle changes, and supportive therapies ...

Diabetic autonomic neuropathy (DAN) is common complication of diabetes mellitus (DM), associated with development of angiopathies and increased mortality. The objective of the study was to determine ...

Naturally reducing HbA1c involves a change of lifestyle, based on conscious eating, constant exercise, emotional balance, and ...

Overweight and obesity are growing health complications mostly associated with metabolic and musculoskeletal comorbidities. The knowledge about the effects of obesity on the plantar pressure ...

Geneva: The World Health Organization (WHO) has issued a global safety alert highlighting the risk of non-arteritic anterior ...

NAION risk is most significant within the first 12 months of beginning semaglutide, and is highest in patients with additional risk factors.

The term “cardiomyopathy” refers to specific diseases affecting the myocardium which generally lead to clinical manifestations of heart failure, including exercise intolerance, dyspnoea, and fluid ...

Dr. Richard Carpenos and his patient share how a non-surgical treatment at New England Spine and Disc is making a difference.

Diabetic peripheral neuropathy is a common complication of diabetes that can affect virtually every tissue of the body and cause significant morbidity and mortality.